| Financial Year |
March 31 2023 |
| Monetary Funds |
54,562,127.10 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
483,704,512.34 |
| Advances to Suppliers |
24,183,171.04 |
| Other Receivables |
61,686,944.33 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
54,518,648.55 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
36,999,836.98 |
| Total Current Assets |
715,655,240.34 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
39,167,266.79 |
| Under-construction Projects |
519,646.03 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
8,653,224.88 |
| R&D expenses |
-- |
| Goodwill |
110,142,408.56 |
| Long-Term Deferred and Prepaid Expenses |
90,001.41 |
| Deferred Income Tax Assets |
10,347,437.81 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
423,816,018.13 |
| Total Assets |
1,139,471,258.47 |
| Short-Term Loans |
25,030,560.26 |
| Trading Financial liabilities |
-- |
| Notes Payable |
595,650.00 |
| Accounts Payable |
329,114,011.05 |
| Accounts Received In Advance |
376,506.59 |
| Employee Compensation Payable |
31,230,445.29 |
| Taxes Payable |
3,750,821.76 |
| Interest Payable |
-- |
| Dividend Payable |
874,026.67 |
| Other payables |
347,768,370.47 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
17,199,914.35 |
| Other Current Liabilities |
27,550,066.42 |
| Sub-Total of Current Liabilities |
871,917,576.52 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
4,139,255.53 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
12,737,835.59 |
| Total Liabilities |
884,655,412.11 |
| Paid-In Capital(Or Share Stock) |
936,291,116.00 |
| Capital Surplus |
1,489,663,826.02 |
| Surplus Reserve |
104,445,528.28 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-2,275,959,518.49 |
| Minority Stockholder's Interest |
374,894.55 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
254,440,951.81 |
| Owner's Equity（Stockholder's Equity） |
254,815,846.36 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,139,471,258.47 |
